Bringing the fundamentals into focus…
Back to Odyssey Therapeutics, Inc.
How Odyssey Therapeutics, Inc. stacks up
ODTX · against 464 other Healthcare companies of similar size
Profitability
1/ 100
Near the bottom of its peers.
Ranked #457 of 465 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 0–9, including ODTX · Click a bar to see the companies
Why profitability scores 1?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 98% of peers. Operating margin: -5415.2% vs peer median 7.1%
- a lower return on invested capital: weaker than 92% of peers. Return on invested capital: -89.3% vs peer median 4.7%
- Return on assets is not reported, so it is left out of the score.
Metric by metric
Position: dot = ODTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ODTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 442 reported | -89.3% | 4.4% | 8% | 33% | |
| Operating marginHigher is better · 434 reported | -5415.2% | 6.8% | 2% | 33% | |
| Return on assetsHigher is better · 453 reported | Not reported | 1.5% | — | — | 33% |
| Return on equityHigher is better · 436 reported | Not reported | 2.7% | — | — | Context only |
| Gross marginHigher is better · 484 reported | 0.0% | 47.2% | 2% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around ODTX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 2 | 578M USD | 99 | 73 | |
| 454 | 1.8B USD | 2 | 23 | |
| 457 | 617M USD | 1 | 28 | |
| 457 | 635M USD | 1 | 39 | |
| 457 | 1.8B USD | 1 | 30 | |
| 457 | 1.0B USD | 1 | 32 | |
| 457 | 825M USD | 1 | 24 | |
| 457 | 1.2B USD | 1 | 21 | |
| 457 | 1.3B USD | 1 | 44 | |
| 464 | 1.2B USD | 0 | 6 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score